Keywords
clinical trials; biomarkers; pharmaceuticals; medical procurement;
Reference
Paul Seabright, “Research into biomarkers: how does drug procurement affect the design of clinical trials?”, Health Management, Policy and Innovation, vol. 1, n. 3, June 2013, pp. 1–15.
See also
Published in
Health Management, Policy and Innovation, vol. 1, n. 3, June 2013, pp. 1–15